Priyanka Verma

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 20, 2026
Endogenous replication stress creates a unique therapeutic window for ALC1 targeting.

|Oct 13, 2026
TET2 loss triggers ssDNA gap accumulation and heightened PARP inhibitor sensitivity.

|Apr 02, 2026
Not All STICs Are Equal: Unraveling the Implications of Precursor Heterogeneity.

T Rinda Soong, Priyanka Verma, Kenneth P Nephew

|Mar 18, 2026
Multimodal imaging reveals a lysosomal drug reservoir that drives heterogeneous distribution of PARP inhibitors.

Carmen R Moncayo, Restuadi Restuadi, Guanying Zhang

|Jul 27, 2024
Nucleolytic processing of abasic sites underlies PARP inhibitor hypersensitivity in ALC1-deficient BRCA mutant cancer cells.

Natasha Ramakrishnan, Tyler M Weaver, Lindsey N Aubuchon

Pageof 1

Frequent Collaborators

2 joint publications

Alessandro Vindigni

1 joint publications

Tyler M Weaver

1 joint publications

Bret D Freudenthal

1 joint publications

Carmen R Moncayo